Kidney RSS News Feeds

Nephrology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Boone M et al. – The results suggest that while activators of the cGMP pathway are likely beneficial in the treatment of X–linked NDI, their ability to relieve NDI in the patients may be improved when combined with agents stimulating AQP2 expression.

Related Articles

Autosomal recessive familial neurohypophyseal diabetes insipidus - onset in early infancy
European Journal of Endocrinology, 11/10/09    Relevance Score: 67%

Diverse Vasopressin V2 Receptor Functionality Underlying Partial Congenital Nephrogenic Diabetes Insipidus
American Journal of Physiology: Renal Physiology, 10/08/09    Relevance Score: 65%

Vasopressin Type 2 Receptor V88M Mutation: Molecular Basis of Partial and Complete Nephrogenic Diabetes Insipidus
Nephron: Physiology, 10/08/09    Relevance Score: 65%

Study: Intervention raises costs for diabetes
Medical Economics, 10/21/09    Relevance Score: 64%

Challenges in management of patients with intracranial germ cell tumor and diabetes insipidus treated with cisplatin and/or ifosfamide based chemotherapy
Journal of Neuro-Oncology, 10/14/09    Relevance Score: 64%

Today in Endocrinology...keeping you current

A Case of Human Intramuscular Adrenal Gland Transplantation as a Cure for Chronic Adrenal Insufficiency
American Journal of Transplantation, 12/08/09

Abnormalities of thyroid function in Japanese patients with metastatic renal cell carcinoma treated with sorafenib: A prospective evaluation
Urologic Oncology: Seminars and Original Investigations, 12/03/09

Response of Secondary Hyperparathyroidism to Cinacalcet Depends on Parathyroid Size
Nephron: Clinical Practice, 12/01/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address